Search
- Jan 10
John Oyler shares an update on BeiGene during San Francisco Healthcare Week
John Oyler discusses BeiGene's BTK, PD1, and other programs, and talks about the company's cost structure.
- Jan 10, 2023
BeiGene on BTK Inhibitors and the Inflation Reduction Act.
John Oyler discusses BeiGene's BTK inhibitor Brukinsa and cautions about the Inflation Reduction Act.